Adenovirus Vector-Based Purging of Multiple Myeloma Cells

Slides:



Advertisements
Similar presentations
Date of download: 11/12/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Retargeting to EGFR Enhances Adenovirus Infection.
Advertisements

An anti-CD19 antibody inhibits the interaction between P-glycoprotein (P-gp) and CD19, causes P-gp to translocate out of lipid rafts, and chemosensitizes.
Magnetic nanoparticles as a new approach to improve the efficacy of gene therapy against differentiated human uterine fibroid cells and tumor-initiating.
Supplementary figure 1. (A) (B) OKF TIGK 104
Lentiviral gene transfer and ex vivo expansion of human primitive stem cells capable of primary, secondary, and tertiary multilineage repopulation in NOD/SCID.
Homocysteine inhibits endothelial cell growth via DNA hypomethylation of the cyclin Agene by Md S. Jamaluddin, Irene Chen, Fan Yang, Xiaohua Jiang, Michael.
Ligand binding to integrin αvβ3requires tyrosine 178 in the αv subunit
Retroviral-Mediated Gene Transduction of c-kit Into Single Hematopoietic Progenitor Cells From Cord Blood Enhances Erythroid Colony Formation and Decreases.
Tissue-Specific Expression of Functional Platelet Factor XI Is Independent of Plasma Factor XI Expression by Chang-jun Hu, Frank A. Baglia, David C.B.
Human Immunodeficiency Virus Type 1 Protease Inhibitor Modulates Activation of Peripheral Blood CD4+ T Cells and Decreases Their Susceptibility to Apoptosis.
C-myb Transactivates the Human Cyclin A1 Promoter and Induces Cyclin A1 Gene Expression by Carsten Müller, Rong Yang, Gregory Idos, Nicola Tidow, Sven.
by Hong Hao, Huiling Qi, and Manohar Ratnam
Characterization of a humanized IgG4 anti-HLA-DR monoclonal antibody that lacks effector cell functions but retains direct antilymphoma activity and increases.
Further Analysis of Interleukin-2 Receptor Subunit Expression on the Different Human Peripheral Blood Mononuclear Cell Subsets by Denis David, Lynda Bani,
Endogenous Tumor Necrosis Factor as a Predictor of Doxorubicin Sensitivity in Leukemic Patients by Daisuke Kobayashi, Naoki Watanabe, Naofumi Yamauchi,
Magnetic nanoparticles as a new approach to improve the efficacy of gene therapy against differentiated human uterine fibroid cells and tumor-initiating.
Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor–κB and IκBα kinase in human multiple myeloma cells, leading to.
CD44-Mediated Adhesiveness of Human Hematopoietic Progenitors to Hyaluronan Is Modulated by Cytokines by Stéphane Legras, Jean-Pierre Lévesque, Rachida.
FOG-1 represses GATA-1-dependent FcϵRI β-chain transcription: transcriptional mechanism of mast-cell-specific gene expression in mice by Keiko Maeda, Chiharu.
CD74 induces TAp63 expression leading to B-cell survival
by Zhengyan Wang, Tina M. Leisner, and Leslie V. Parise
MafB negatively regulates RANKL-mediated osteoclast differentiation
by Rong L. He, Jian Zhou, Crystal Z
Identification of primary structural features that define the differential actions of IL-3 and GM-CSF receptors by Caroline A. Evans, Shahrul Ariffin,
Epstein-Barr virus–specific human T lymphocytes expressing antitumor chimeric T-cell receptors: potential for improved immunotherapy by Claudia Rossig,
by Kirsteen H. Maclean, John L. Cleveland, and John B. Porter
Exposure to fluid shear stress modulates the ability of endothelial cells to recruit neutrophils in response to tumor necrosis factor-α: a basis for local.
Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion by Yenan T. Bryceson, Michael E. March, Hans-Gustaf.
T-cell activation and cytokine production via a bispecific single-chain antibody fragment targeted to blood-stage malaria parasites by Shigeto Yoshida,
Apoptotic Regulation in Primitive Hematopoietic Precursors
Ex vivo induction of multiple myeloma–specific cytotoxic T lymphocytes
Macrophages from C3-deficient mice have impaired potency to stimulate alloreactive T cells by Wuding Zhou, Hetal Patel, Ke Li, Qi Peng, Marie-Bernadette.
Efficient gene transfer of CD40 ligand into primary B-CLL cells using recombinant adeno-associated virus (rAAV) vectors by Clemens-Martin Wendtner, David.
Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy by Mark P. Chao, Chad Tang, Russell K. Pachynski,
A chemical biology screen identifies glucocorticoids that regulate c-maf expression by increasing its proteasomal degradation through up-regulation of.
by Quanzhi Li, Joy L. Frestedt, and John H. Kersey
by Éric Aubin, Réal Lemieux, and Renée Bazin
by Herbert Bosshart, and Ruth F. Jarrett
Specific Lysis of Melanoma Cells by Receptor Grafted T Cells is Enhanced by Anti- Idiotypic Monoclonal Antibodies Directed to the scFv Domain of the Receptor 
Arsenic suppresses gene expression in promyelocytic leukemia cells partly through Sp1 oxidation by Wen-Chien Chou, Hsuan-Yu Chen, Sung-Liang Yu, Linzhao.
Apoptotic Vascular Endothelial Cells Become Procoagulant
Volume 130, Issue 2, Pages (February 2006)
A Three Amino Acid Deletion in Glycoprotein IIIa Is Responsible for Type I Glanzmann's Thrombasthenia: Importance of Residues Ile325Pro326Gly327 for β3.
by Shrikanth P. Hegde, JingFeng Zhao, Richard A. Ashmun, and Linda H
A Strong Expression of CD44-6v Correlates With Shorter Survival of Patients With Acute Myeloid Leukemia by S. Legras, U. Günthert, R. Stauder, F. Curt,
Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone.
Volume 14, Issue 3, Pages (September 2006)
Ex Vivo Cultured Megakaryocytes Express Functional Glycoprotein IIb-IIIa Receptors and Are Capable of Adenovirus-Mediated Transgene Expression by Nauder.
Volume 10, Issue 1, Pages (July 2004)
Human Keratinocytes Express Functional CD14 and Toll-Like Receptor 4
Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion by John D. Belcher, Paul H. Marker,
CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results by Brian.
Pim-1 is up-regulated by constitutively activated FLT3 and plays a role in FLT3-mediated cell survival by Kyu-Tae Kim, Kristin Baird, Joon-Young Ahn, Paul.
Volume 9, Issue 6, Pages (June 2004)
Selective Purging of Human Multiple Myeloma Cells from Autologous Stem Cell Transplantation Grafts using Oncolytic Myxoma Virus  Eric Bartee, Winnie M.
Volume 26, Issue 2, Pages (February 2018)
Granulocyte–Macrophage Colony-Stimulating Factor Gene Transfer to Dendritic Cells or Epidermal Cells Augments Their Antigen-Presenting Function Including.
Human Papilloma Virus E6 and E7 Proteins Support DNA Replication of Adenoviruses Deleted for the E1A and E1B Genes  Dirk S. Steinwaerder, Cheryl A. Carlson,
Volume 13, Issue 1, Pages (January 2006)
Volume 6, Issue 2, Pages (August 2002)
P38 Mitogen-Activated Protein Kinase Mediates Dual Role of Ultraviolet B Radiation in Induction of Maturation and Apoptosis of Monocyte-Derived Dendritic.
Exosomal regulation of lymphocyte homing to the gut
Volume 24, Issue 1, Pages (January 2016)
Regulation of human renin gene promoter activity: A new negative regulatory region determines the responsiveness to TNFα  Ling-Sing K. Chen, Michael P.
Volume 3, Issue 5, Pages (May 2001)
Volume 8, Issue 1, Pages (July 2003)
Bcl-2 and bcl-xL Antisense Oligonucleotides Induce Apoptosis in Melanoma Cells of Different Clinical Stages  Robert A. Olie, Christoph Hafner, Renzo Küttel,
Adoptive transfer of gene-engineered CD4+ helper T cells induces potent primary and secondary tumor rejection by Maria Moeller, Nicole M. Haynes, Michael.
MDM2 Protein Overexpression Inhibits Apoptosis of TF-1 Granulocyte-Macrophage Colony-Stimulating Factor–Dependent Acute Myeloblastic Leukemia Cells by.
Expression of CAR, endogenous TCR, and target-cell receptors.
Presentation transcript:

Adenovirus Vector-Based Purging of Multiple Myeloma Cells by Gerrard Teoh, Ling Chen, Mitsuyoshi Urashima, Yu-Tzu Tai, Leo A. Celi, Dongshu Chen, Dharminder Chauhan, Atsushi Ogata, Robert W. Finberg, Iain J. Webb, Donald W. Kufe, and Kenneth C. Anderson Blood Volume 92(12):4591-4601 December 15, 1998 ©1998 by American Society of Hematology

Expression of CAR adenovirus receptor on HeLa cells; OCI-My5, RPMI 8226, ARH-77, HS Sultan, and IM-9 MM cells; patient MM1 cells; normal B splenocytes; CESS and JY EBV-transformed B cells; and normal BM MNCs. Cells (5 × 105/mL) were stained with RmcB anti-C... Expression of CAR adenovirus receptor on HeLa cells; OCI-My5, RPMI 8226, ARH-77, HS Sultan, and IM-9 MM cells; patient MM1 cells; normal B splenocytes; CESS and JY EBV-transformed B cells; and normal BM MNCs. Cells (5 × 105/mL) were stained with RmcB anti-CAR MoAb (1:100) followed by 1 μL of FITC-conjugated goat (Fab′)2 antimouse IgG MoAb, or with 5 μL of FITC-conjugated mouse IgG1 (isotype control), and analyzed by indirect immunofluorescence flow cytometry. Cells examined included RD PCR3 (A; negative control) and RD CAR (B; positive control) cells; HeLa (C) cells, known to express adenovirus receptors; OCI-My5 (D), RPMI 8226 (E), ARH-77 (F), HS Sultan (G), and IM-9 (H) MM cells; patient MM1 (I) cells; normal B splenocytes (J); CESS (K) and JY (L) EBV-transformed B cells; and normal BM MNCs (M). Gerrard Teoh et al. Blood 1998;92:4591-4601 ©1998 by American Society of Hematology

Specific 35S-Ad2 binding to HeLa cells; to OCI-My5, RPMI 8226, ARH-77, HS Sultan, and IM-9 MM cells; to patient MM1 cells; to normal B splenocytes; to CESS and JY EBV-transformed B cells; and to normal BM MNCs. HeLa cells; OCI-My5, RPMI 8226, ARH-77, HS Sul... Specific 35S-Ad2 binding to HeLa cells; to OCI-My5, RPMI 8226, ARH-77, HS Sultan, and IM-9 MM cells; to patient MM1 cells; to normal B splenocytes; to CESS and JY EBV-transformed B cells; and to normal BM MNCs. HeLa cells; OCI-My5, RPMI 8226, ARH-77, HS Sultan, and IM-9 MM cells; patient MM1 cells; normal B splenocytes; CESS and JY EBV-transformed B cells; and normal BM MNCs (1 × 106) were incubated with either RmcB anti-CAR MoAb (1:100) or 5E2B4 mouse MoAb (IgG2; 1:100; isotype control), followed by incubation with 35S-labeled Ad2, and then washed, solubilized, and analyzed on a β-counter. The percentage of specific Ad2 binding (difference in Ad2 binding by 5E2B4-treated versus RmcB-treated cells) relative to control HeLa cells (100% specific Ad2 binding) was determined. RD PCR3 and RD CAR transfectants served as negative and positive controls, respectively. Gerrard Teoh et al. Blood 1998;92:4591-4601 ©1998 by American Society of Hematology

Expression of vβ5 integrin and DF3/MUC1 on OCI-My5 and RPMI 8226 MM cells and on patient MM1 cells. Expression of vβ5 integrin and DF3/MUC1 on OCI-My5 and RPMI 8226 MM cells and on patient MM1 cells. OCI-My5 and RPMI 8226 MM cells and patient MM1 cells (5 × 105/mL) were stained with 1 μL of either vβ5 MoAb (A) or anti-DF3/MUC1 MoAb (B), followed by 1 μL of FITC-conjugated goat (Fab′)2antimouse IgG MoAb, or with 5 μL of FITC-conjugated mouse IgG1 alone (isotype control). The percentage of cells expressing these antigens was determined using indirect immunofluorescence flow cytometric analysis. Gerrard Teoh et al. Blood 1998;92:4591-4601 ©1998 by American Society of Hematology

Efficiency of Ad vector transduction assessed byβ-gal reporter gene expression in OCI-My5 and RPMI 8226 MM cells, as well as RPMI 8226 MM cells within normal BM MNCs. OCI-My5 and RPMI 8226 MM cells (5 × 105/mL) were transduced with Ad.DF3-βgal at MOI = 1 fo... Efficiency of Ad vector transduction assessed byβ-gal reporter gene expression in OCI-My5 and RPMI 8226 MM cells, as well as RPMI 8226 MM cells within normal BM MNCs. OCI-My5 and RPMI 8226 MM cells (5 × 105/mL) were transduced with Ad.DF3-βgal at MOI = 1 for 2 hours, incubated with FDG, and analyzed by fluorescence flow cytometry at 24 hours (A). These tumor cells were also transduced with Ad.DF3-βgal (▪) or Ad.CMV-βgal (□) at MOI = 10 for 2 hours and analyzed by chemiluminescence assay at 24 hours (B). Mock-irradiated (□) and γ-irradiated (▪; 2.0 Gy) normal BM MNCs (3 × 104/well) were cultured in media alone or transduced with either Ad.CMV-βgal or Ad.DF3-βgal (both MOI = 100) for 2 hours and then analyzed by X-Gal staining at 24 hours (n = 3). X-Gal staining of mock-irradiated and γ-irradiated BM MNCs was compared with untransduced normal BM MNCs (negative control) and RPMI 8226 MM cells (positive control; C). RPMI 8226 MM cells (0.0%, 0.0001%, 0.001%, and 0.01%) mixed with normal BM MNCs were transduced with Ad.DF3-βgal at MOI = 1 for 2 hours and similarly analyzed using a chemiluminescence assay at 24 hours (n = 3; D). Gerrard Teoh et al. Blood 1998;92:4591-4601 ©1998 by American Society of Hematology

Treatment with GCV to purge Ad Treatment with GCV to purge Ad.DF3-tk–transduced OCI-My5 and RPMI 8226 MM cells within BM MNCs. To construct standard curves for measuring residual viable tumor cell contamination after purging, OCI-My5 cells (A) or RPMI 8226 MM cells (B; 0 to 1 × 106 cells... Treatment with GCV to purge Ad.DF3-tk–transduced OCI-My5 and RPMI 8226 MM cells within BM MNCs. To construct standard curves for measuring residual viable tumor cell contamination after purging, OCI-My5 cells (A) or RPMI 8226 MM cells (B; 0 to 1 × 106 cells) were incubated in triplicate with 3H-TdR (1 μCi) for 12 hours, harvested, and analyzed on a β-counter. OCI-My5 (C) and RPMI 8226 MM cells (D; 2 × 105 cells) were mixed with γ-irradiated (2.0 Gy) normal BM MNCs (2 × 106 cells). BM MNCs containing tumor cells were transduced with Ad.DF3-tk at MOI = 1, MOI = 10, or MOI = 100 or with Ad.CMV-tk at MOI = 10 for 2 hours, washed out for 10 hours, and treated with GCV at 0 (□), 0.5 (▨), 5 (░), or 50 (▪) μmol/L for 36 hours. 3H-TdR incorporation was measured as described above and compared with that for nontransfected tumor cell in BM MNC controls. CESS (E) and JY (F) EBV-transformed B cells, which do not express adenoviral receptors, served as negative controls. All experiments were performed in triplicate. Log depeletion of OCI-My5 (G) and RPMI 8226 (H) MM cells with Ad.DF3-tk at MOI = 100 and 50 μmol/L GCV is shown. Gerrard Teoh et al. Blood 1998;92:4591-4601 ©1998 by American Society of Hematology

Detection of Ad5 E2B adenoviral DNA in RPMI 8226 MM cells, patient MM2 cells, and normal BM MNCS transduced with Ad.DF3-tk and then treated with GCV. RPMI 8226 MM cells (A) or patient MM2 cells (B; 1 × 103/sample; lanes 1 through 4); RPMI 8226 MM cells (A) ... Detection of Ad5 E2B adenoviral DNA in RPMI 8226 MM cells, patient MM2 cells, and normal BM MNCS transduced with Ad.DF3-tk and then treated with GCV. RPMI 8226 MM cells (A) or patient MM2 cells (B; 1 × 103/sample; lanes 1 through 4); RPMI 8226 MM cells (A) or patient MM2 cells (B; 1 × 103/sample) mixed with normal BM MNCs (1 × 104/sample; lanes 5 through 8); or normal BM MNCs (1 × 104/sample; lanes 9 through 12) were either nontransduced (lanes 1, 2, 5, 6, 9, and 10) or transduced with Ad.DF3-tk (MOI = 100; lanes 3, 4, 7, 8, 11, and 12) for 2 hours and then washed out for 10 hours. Cells were next cultured with GCV (50 μmol/L; lanes 2, 4, 6, 8, 10, and 12) or without GCV (lanes 1, 3, 5, 7, 9, and 11) for 36 hours. The E2B gene was amplified by PCR, as previously reported,17 28 from viral DNA extracted following cell lysis. Viral DNA obtained from Ad.DF3-tk particles (1 × 103 to 1 × 105 PFU) served as a positive control (lanes 13 through 15). PCR for β-actin confirmed integrity of DNA. Gerrard Teoh et al. Blood 1998;92:4591-4601 ©1998 by American Society of Hematology

Bystander effect after GCV treatment oftk-transduced RPMI 8226 MM cells. Bystander effect after GCV treatment oftk-transduced RPMI 8226 MM cells. RPMI 8226 MM cells (3 × 104/well) were transduced with Ad.CMV-βgal or Ad.CMV-tk (•) or with Ad.DF3-βgal or Ad.DF3-tk (○) at MOI = 0, 1, 5, 10, 50, and 100 for 2 hours. Cells were washed out for 10 hours, and tk-transduced tumor cells were then treated with GCV (50 μmol/L) for 36 hours. The bystander effect was determined by comparing the percentage of transduced cells after Ad.CMV-βgal and Ad.DF3-βgaltransduction, assessed by X-Gal staining, with the percentage of cells killed after GCV treatment of Ad.CMV-tk– and Ad.DF3-tk–transduced cells, assessed by trypan blue exclusion. HeLa cervical carcinoma cells (▴), known to demonstrate the bystander effect,34 were similarly transduced with Ad.CMV-βgal or Ad.CMV-tk and served as positive controls. Gerrard Teoh et al. Blood 1998;92:4591-4601 ©1998 by American Society of Hematology

Specificity of the DF3 promoter for RPMI 8226 MM cells. Specificity of the DF3 promoter for RPMI 8226 MM cells. DF3-positive RPMI 8226 MM and DF3-negative HeLa cervical carcinoma cells (3 × 104/well) were transduced with Ad.CMV-βgal (A and B; □) and Ad.CMV-tk (C and D, □) or with Ad.DF3-βgal (A and B, ▪) and Ad.DF3-tk(C and D, ▪) at MOI = 0, 1, 5, 10, 50, and 100 for 2 hours. Cells were washed out for 10 hours and tk-transduced tumor cells were then treated with GCV (50 μmol/L) for 36 hours. Comparison of the transduction efficiency (ie, X-Gal staining after transduction with Ad.CMV-βgal or Ad.DF3-βgal) and GCV killing oftk-transduced tumor cells (ie, viable cells by trypan blue exclusion after transduction with Ad.CMV-tk and Ad.DF3-tk followed by GCV treatment) was compared for Ad.CMV versus Ad.DF3 promoters. Gerrard Teoh et al. Blood 1998;92:4591-4601 ©1998 by American Society of Hematology